MGX

Metagenomi Therapeutics, Inc. - Common Stock (MGX)

About Metagenomi Therapeutics, Inc. - Common Stock (MGX)

Metagenomi Therapeutics, Inc. is a precision genetic medicines company, which engages in the business of developing next generation gene-editing technologies and therapies. Its business activities include developing gene edit­ing toolbox, ther­a­peu­tic focus, and processing discovery platform. The company was founded by Brian C. Thomas on September 16, 2016 and is headquartered in Emeryville, CA.

Details

Daily high
$1.14
Daily low
$1.09
Price at open
$1.11
52 Week High
$3.95
52 Week Low
$1.09
Market cap
41.6M
Dividend yield
-
Volume
1,901
Avg. volume
155,360
P/E ratio
-.44

Metagenomi Therapeutics, Inc. - Common Stock News

Details

Daily high
$1.14
Daily low
$1.09
Price at open
$1.11
52 Week High
$3.95
52 Week Low
$1.09
Market cap
41.6M
Dividend yield
-
Volume
1,901
Avg. volume
155,360
P/E ratio
-.44